We are live on ! Find out more
DS

David Shaw D.E. Shaw & Co

AUM $210B
1-Year Est. Return 57.28%
 

David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.

This Fund
S&P 500
This Quarter Est. Return
-2.98%
1 Year Est. Return
+57.28%
3 Year Est. Return
+174.65%
5 Year Est. Return
+213.13%
10 Year Est. Return
+910.08%
AUM
$112B
AUM Growth
-$23.9B
Cap. Flow
-$21.6B
Cap. Flow %
-19.26%
Top 10 Hldgs %
10.96%
Holding
4,902
New
569
Increased
1,472
Reduced
1,734
Closed
704

Sector Composition

Rank Sector Weight
1 Technology 15.18%
2 Healthcare 9.91%
3 Consumer Discretionary 9.25%
4 Financials 6.45%
5 Industrials 5.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WW
3951
PUT
DELISTED
WW International
WW
$36.6K ﹤0.01%
70,000
-200
-0.3% -$174
MGNX icon
3952
MacroGenics
MGNX
$256M
$36.4K ﹤0.01%
+28,700
New +$75K
IROHR
3953
DELISTED
Iron Horse Acquisitions Corp Right
IROHR
$35.7K ﹤0.01%
119,035
NOEMW
3954
CO2 Energy Transition Corp Warrant
NOEMW
$897K
$35K ﹤0.01%
+280,000
New +$24.3K
PL.WS
3955
DELISTED
Planet Labs PBC Warrants
PL.WS
$34.3K ﹤0.01%
52,798
BRLSW icon
3956
Borealis Foods Inc Warrant
BRLSW
$1.11M
$33.3K ﹤0.01%
300,000
SBCWW
3957
SBC Medical Group Warrants
SBCWW
$3.45M
$32.1K ﹤0.01%
172,500
GSRTR
3958
DELISTED
GSR III Acquisition Corp Right
GSRTR
$31.5K ﹤0.01%
21,428
NMRA icon
3959
Neumora Therapeutics
NMRA
$286M
$30.7K ﹤0.01%
+30,748
New +$52.6K
ANSCW
3960
DELISTED
Agriculture & Natural Solutions Acquisition Corp Warrant
ANSCW
$30K ﹤0.01%
100,000
TAVIR
3961
Tavia Acquisition Corp Right
TAVIR
$30K ﹤0.01%
200,000
AAM.WS
3962
DELISTED
AA Mission Acquisition Corp Warrants
AAM.WS
$29.9K ﹤0.01%
450,000
ANVS icon
3963
Annovis Bio
ANVS
$74.6M
$28.2K ﹤0.01%
+18,789
New +$57.5K
BDTX icon
3964
Black Diamond Therapeutics
BDTX
$124M
$27.7K ﹤0.01%
17,854
+537
+3% +$1.13K
CHARR
3965
Charlton Aria Acquisition Corp Rights
CHARR
$27K ﹤0.01%
150,000
LEGT.WS
3966
DELISTED
Legato Merger Corp III Warrants
LEGT.WS
$26.3K ﹤0.01%
136,100
BUJAR
3967
DELISTED
Bukit Jalil Global Acquisition 1 Ltd. Rights
BUJAR
$26K ﹤0.01%
100,000
RDACR
3968
Rising Dragon Acquisition Corp Rights
RDACR
$24.2K ﹤0.01%
150,000
EUDAW icon
3969
EUDA Health Holdings Warrant
EUDAW
$268K
$24K ﹤0.01%
200,000
DTSQR
3970
DT Cloud Star Acquisition Corp Right
DTSQR
$23.7K ﹤0.01%
150,000
AEVAW
3971
DELISTED
Aeva Technologies Warrants
AEVAW
$23.2K ﹤0.01%
294,000
BKHAR
3972
Black Hawk Acquisition Corp Rights
BKHAR
$22.5K ﹤0.01%
15,000
GLACR
3973
DELISTED
Global Lights Acquisition Corp Rights
GLACR
$22K ﹤0.01%
100,000
MACIW
3974
Melar Acquisition Corp I Warrant
MACIW
$960K
$21.9K ﹤0.01%
162,500
TLRY icon
3975
Tilray
TLRY
$649M
$21.6K ﹤0.01%
+3,289
New +$30.4K

Similar funds

David Shaw's Q1 2025 Portfolio in Review

As of Q1 2025, David Shaw held 4,902 positions worth $112B, down 18% from $136B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

David Shaw withdrew a net $21.6B in Q1 2025, closing 704 positions and reducing 1,734 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $951M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, David Shaw opened a new position in KKR & Co 6.25% Series D Preferred Stock worth $88.2M.

  • David Shaw's largest Q1 2025 buy was KKR & Co 6.25% Series D Preferred Stock: 1,800,000 shares worth $88.2M.
  • David Shaw added most to GE Vernova in Q1 2025, an estimated $686M increase.
  • David Shaw's biggest Q1 2025 reduction was Boeing, cutting an estimated $981M.
  • David Shaw fully exited iShares Core S&P 500 ETF in Q1 2025, selling an estimated $951M.
  • David Shaw's ten largest holdings make up 11% of its $112B portfolio in Q1 2025.
  • David Shaw opened 569 new positions and closed 704 in Q1 2025.
  • David Shaw's portfolio value fell 18% quarter-over-quarter to $112B.

Based on D.E. Shaw & Co's 13F filing for Q1 2025, filed 15 May 2025.